HB 1333: Individualized Investigational Treatments
GENERAL BILL by Gerwig
Individualized Investigational Treatments ; Authorizes certain actions by eligible facilities, manufacturers operating within eligible facilities, & eligible patients relating to individualized investigational treatments; authorizes health plans, third-party administrators, & governmental agencies to provide coverage for cost of individualized investigational drug, biological product, or device, or cost of certain services; limits liability; prohibits licensing boards, disciplinary subcommittees, & entities responsible for Medicare certification from taking certain actions against health care provider's license; prohibits certain persons from blocking or attempting to block eligible patient's access to individualized investigational drug, biological product, or device; provides construction.
-
Bill History
Date Chamber Action 2/27/2025 House • Filed
-
HB 1333, Original Filed Version (Current Bill Version) Posted 2/27/2025 at 12:27 PM
Bill Text: PDF Analyses: None Related Bills (1)
Bill Number Subject Filed By Relationship Last Action and Location Track Bills S 680 Individualized Investigational Treatments for Life-threatening or Severely Debilitating Illnesses Rodriguez Similar Last Action: 2/25/2025 S Referred to Health Policy; Appropriations Committee on Health and Human Services; Rules 
Citations - Statutes (1)
Citation Catchline Location in Bill Location In Bill Help 381.992 Page 2 (pdf)